key: cord-0869672-6d90gqts
authors: Espana, G.; Cucunuba, Z. M.; Cuervo-Rojas, J.; Diaz, H.; Gonzalez-Mayorga, M.; Ramirez, J. D.
title: The potential impact of delta variant of SARS-CoV-2 in the context of limited vaccination coverage and increasing social mixing in Bogota, Colombia
date: 2021-08-07
journal: nan
DOI: 10.1101/2021.08.06.21261734
sha: a33c859fcac1b13d40eddb553efa44927c0a84c8
doc_id: 869672
cord_uid: 6d90gqts

Background: More than 122,000 COVID-19 associated deaths have been reported in Colombia and about 27,000 in the city of Bogota by the first week of August, with vaccination coverage in the city at 30% for complete schemes and at 37% for partial vaccination. As the incidence of cases currently decreases, questions remain about the potential impact of the delta variant already present in the city. Methods: We used an agent-based model calibrated to data on age-structured deaths and dominance of variants in Bogota. We used efficacy data for the portfolio of vaccines available, including known changes for SARS-CoV-2 variants. We modelled scenarios of early and delayed introduction of the delta variant in the city along with changes in mobility and social contact, and vaccine strategies over the next months. Findings: We estimate that by mid July, vaccination may have already prevented 17,800 (95% CrI: 16,000 - 19,000) deaths in Bogota. The delta variant could become dominant and lead to a fourth wave later in the year, but its timing will depend on the date of introduction, social mixing patterns, and vaccination strategy. In all scenarios, higher social mixing is associated with a fourth wave of considerable magnitude. If an early delta introduction occurred (dominance by mid July), a new wave may occur in August/September and in such case, age prioritization of vaccination and second dose not postponed are more important. However, if introduction occurred one or two months later (dominance by mid August/September) the age-prioritization is less relevant but maintaining the dose scheme without postponement is more important. In all scenarios we found that increasing the vaccination rate from the current average of 50,000/day to 100,000/day reduces the impact of a fourth wave due to the delta variant. Conclusions: In Bogota, the delta variant could still lead to a fourth wave, whose magnitude would depend on its introduction time and the level of social mixing. Its impact can be mitigated by increasing vaccination rates to achieve high coverage quickly, with non-delayed second doses. We found that, at this point, suspending the age prioritization to achieve higher coverage with first doses does not seem to have a major effect on deaths and ICU demand. But, delaying the second dose may not be beneficial and may even increase the incidence of severe outcomes.

The baseline model assumes that the delta variant has already been introduced in the city but it is 118 still not dominant. Projections show a fourth wave of COVID-19 in the city due to the delta 119 variant, however its magnitude may depend on the date of introduction of delta, the social 120 mixing patterns, and the vaccination coverage achieved at the time of dominance (Fig 2) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 7, 2021. ; https://doi.org/10.1101/2021.08.06.21261734 doi: medRxiv preprint variant (Fig 2) . With high social mixing, an early introduction of delta would result in a peak of 129 189 (95% CrI: 160-245) daily deaths, whereas a late introduction would cause a peak of 130 130 (95% CrI: 116 -180). In both scenarios of the timing of delta, reduced social mixing resulted in a 131 smaller peak. With moderate social mixing, an early introduction of delta would result in a peak 132 of 104 (95% CrI: 77-150) daily deaths, compared to 59 (95% CrI: 47-136) daily deaths in the 133 scenario of late introduction of delta. left column). In the scenario in which delta introduction occurs two months later (dominance in 144 October), the age-prioritization for adults is less relevant but maintaining the dose scheme 145 without postponement is more important. In this scenario, we found that increasing the 146 vaccination rate to 100,000/day (the maximum possible according to health authorities) could 147 have a larger impact in reducing the burden of a fourth wave due to the delta variant. These CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted August 7, 2021. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted August 7, 2021. ; https://doi.org/10.1101/2021.08.06.21261734 doi: medRxiv preprint 

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted August 7, 2021. ; https://doi.org/10.1101/2021.08.06.21261734 doi: medRxiv preprint

We simulated the impact of the introduction of the delta variant with an agent-based model that 176 includes a detailed representation of the population of Bogotá by age, geographic location, and 177 main social activities and mobility patterns (schools, universities, workplaces, long-term care 178 facilities, households, and neighborhoods). This model has been previously validated to COVID-179 19 dynamics in various places [10, 11] . We found that the increased number of cases and deaths 180 during the third wave of COVID-19 in the city could be explained by a combination of higher 181 mobility and social contacts, along with the presence of variants of concern or interest, in CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 7, 2021. To calibrate the parameters related to transmission and immunity escape for the different 285 variants, we used the ranges reported in the literature ( Table 1 ). The date of introduction of 286 variants was estimated using reported cases from international travelers and the prevalence of CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 7, 2021. ; https://doi.org/10.1101/2021.08.06.21261734 doi: medRxiv preprint proportion of importations detected in the city from country 'c'; and ! is a scaling factor 296 estimated using daily deaths and dominance data from sequenced samples. Table S1 ). We assumed that vaccines have some level of protection against infection. Given the 314 uncertainty in this regard, in our main analyses we assumed that protection against infection is 315 50% of that reported for symptomatic disease. We also considered an alternative scenario of is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 7, 2021. ; https://doi.org/10.1101/2021.08.06.21261734 doi: medRxiv preprint

To project the future delivery of vaccines, we assumed constant availability with the proportion 320 of vaccine types determined by the current one. In terms of the daily capacity of vaccine 321 administration, we assumed that the current daily vaccination rates would remain until the target 322 population is completely vaccinated. We also assume a probability of vaccine uptake of 90%.

Simulation scenarios 325 We assessed the potential impact of delta variant introduction in the city by calibrating the CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 7, 2021. ; https://doi.org/10.1101/2021.08.06.21261734 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 7, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 7, 2021. 

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted August 7, 2021. ; https://doi.org/10.1101/2021.08.06.21261734 doi: medRxiv preprint CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted August 7, 2021. ; https://doi.org/10.1101/2021.08.06.21261734 doi: medRxiv preprint (100,000/day) without age priority. Green colors show the impact of increased vaccination rates (100,000/day) with age priority.

Gray colors show the impact of baseline vaccination rates without age priority. 425 426 427 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted August 7, 2021. ; https://doi.org/10.1101/2021.08.06.21261734 doi: medRxiv preprint

Instituto Nacional de Salud, Colombia. Datos Coronavirus Colombia

agent based modeling study

COVID-19 vaccine efficacy data: solid enough to delay second 464 dose? The Lancet

Covid-19 vaccination: What's the evidence for extending the 466 dosing interval?

Delaying a COVID vaccine's second dose boosts immune response

Single-dose administration and the influence of the timing of the booster dose on 471 immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis 472 of four randomised trials

Instituto Nacional de Salud, Colombia. Datos Coronavirus Colombia

Seroprevalence of Anti-Sars-Cov-2 Antibodies in Colombia